Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 51-88

  Yewdell, Jonathan W ^a   Bennink, Jack R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antigen processing; CTL; Immunodominance; MHC

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; GENES, MHC CLASS I; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; PEPTIDES; T-LYMPHOCYTES;

EID: 0033046472     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.51     Document Type: Review

References (117)

1. Zinkernagel RM, Doherty PC. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningilis within a syngeneic or semiallogeneic system. Nature 248:701-2
2. Zinkernagel RM, Doherty PC. 1979. MHC-restricted cytotoxic T cells:studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:52-180
3. Bennink JR, Yewdell JW, Smith GL, Moss B. 1987. Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein:responsiveness to individual viral antigens is major histocompatibility complex controlled. J. Virol. 61:1098-102
4. Gotch F, McMichael A, Smith G, Moss B. 1987. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J. Exp. Med. 165:408-16
5. Townsend ARM, Gotch FM, Davey J. 1985. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457-67
6. Falk K, Rötzschke O, Deres K, Metzger J, Jung G, Rammensee H-G. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425-34
7. Townsend ARM, Rothbard J, Gothch FM, Bahadur G, Wraith D, McMichael AF. 1986. The epitopes of influenza virus nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959-68
8. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. 1993. Dominance and crypticity of T cell antigenic determinants. Anna. Rev. Immunol. 11:729-66
9. Madden DR. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol 13:587-622
10. Rammensee H-G, Bachmann J, Stevanovic S. 1997. MHC Ligands and Peptide Motifs, Austin, TX:Landes Biosci.
11. Engelhard VH. 1994. Structure of peptides associated with MHC class 1 molecules. Curr. Op. Immunol. 6:13-23
12. Pamer E, Cresswell P. 1998. Mechanisms of MHC class 1-restricted antigen processing. Annu. Rev. Immunol. 16:323-58
13. Elliott T. 1997. Transporter associated with antigen processing. Adv. Immunol. 65:47-109
14. Momburg F, Hammerling GJ. 1998. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv. Immunol 68:191-256
15. Tanaka K, Tanahashi N, Tsurumi C, Yokota K-Y, Shimbara N. 1997. Proteasomes and antigen processing. Adv. Immunol. 64:1-38
16. LI S, Sjogren HO, Hellman U, Pettersson RF, Wang P. 1997. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 94:8708-13
17. Srivastava PK. 1993. Peptide-binding heat shock proteins in the endoplasmic reticulum:role in immune response to cancer and in antigen presentation. Adv. Cancer Research. 62:153-77
18. Sykulev Y, Cohen RJ, Eisen HN. 1995. The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic lymphocytes. Proc. Natl. Acad. Sci. USA 92:11990-92
19. Kageyama S, Tsomides TJ, Sykulev Y, Eisen HN. 1995. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 154:567-76
20. Sette A, Alexander J, Snoke K, Grey HM, 1996. Antigen analogs as tools to study T-cell activation function and activation, Semin. Immunol. 8:103-8
21. Sloan-Lancaster J, Allen PM. 1996. Altered peptide ligand-induced partial T cell activation:molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27
22. Bevan MJ. 1995. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182:639-41
23. Srivastava PK, Heike M. 1991. Tumor-specific immunogenicity of stress-induced proteins:convergence of two evolutionary pathways of antigen presentation? Semin. Immunol. 3:57-64
24. Jondal M, Schirmbeck K, Reimann J. 1996. MHC class 1-restricted CTL responses to exogenous antigens. Immunity 5:295-302
25. McMichael AJ, O'Callaghan CA. 1998. A new look at T cells. J. Exp. Med. 187:1367-71
26. Andersen PS, Stryhn A, Hansen BE, Fugger L, Engberg L, Buus S. 1996. A recombinant antibody with the antigen-specific major histocompatibility complex-restricted specificity of T cells. Proc. Natl. Acad. Sci USA 93:1820-24
27. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715-26
28. Meadows L, Wang W, den Haan JMM, Blokland E, Reinhardus C, Drijfhout JW, Shabanowitz J, Pierce R, Agulnik AI, Bishop CE, Hunt DF, Goulmy E, Engelhard VH. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273-81
29. Sette A, Sidney J, Del Guercio M-F, Southwood S, Ruppert J, Dahlberg C, Grey HM, Kudo RT. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813-22
30. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WA, Melief CJM, Oseroff C, Yuan L, Ruppert J, Sidney J, Guercio MFd, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epotopes. J. Immunol. 153:5586-92
31. LaFace DM, Vestberg M, Yang Y, Srivastava R, DiSanto J, Flomenberg N, Brown S, Sherman LA, Peterson PA. 1995. Human CD8 transgene regulation of HLA recognition by murine T cells. J. Exp. Med. 182:1315-25
32. Sun J, Leahy DJ, Kavathas PB. 1995. Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I. J. Exp. Med. 182:1275-80
33. Parker KC, Bednarek MA, Coligan JE. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-75
34. Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A. 1997. Derivation of HLA-A11/Kb transgenic mice:functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J. Immunol. 159:4753-61
35. van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Sette A, Ahmed R. 1998. Identification of Db-and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriorneningitis virus-infected mice. Virology 240:158-67
36. van der Most RG, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau LL, Southwood S, Sidney J, Chestnut RW, Matloubian M, Ahmed R. 1996. Analysis of cytotoxic T cells responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543-54
37. van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Sette A, Ahmed R. 1998. Identification of Db-and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158-67
38. b-restricted epitopes. J. Immunol. 157:5555-62
39. Deng Y, Yewdell JW, Eisenlohr LC, Bennink JR. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507-15
40. Udaka K, Wiesmüller K-H, Kienle S, Jung G, Walden P. 1995. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J. Exp. Med. 181:2097-108
41. Stryhn A, Petersen LO, Romme T, Holm CB, Holm A, Buus S. 1996. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificilies:quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol. 26:1911-18
42. Gavin MA, Dere B, Grandea AG, Hogquist KA, Bevan MJ. 1994. Major histocompatibility complex class I allele-specific peptide libraries:identification of peptides that mimic an H-Y T cell epitope. Eur. J. Immunol. 24:2124-33
43. Rowland-Jones S, Tan R, McMichael A. 1997. Role of cellular immunity in proteclion against HIV infection. Adv. Immunol. 65:277-346
44. Pantaleo G, Fauci AS. 1995. New concepts in the pathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512
45. Rickinson AB, Moss DJ. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-31
46. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol. 70:7569-79
47. Fu T-M, Friedman A, Ulmer JB, Liu MA, Donnelly JJ. 1997. Protective cellular immunity:cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71:2715-21
48. + T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. J. Immunol. 160:2425-32
49. Oukka M, Manuguerra JC, Livaditis N, Tourdot S, Riche N, Vergnon I, Cordopatis P, Kosmatopoulos K. 1996. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J. Immunol 157:3039-45
50. Lewicki HA, Von Herrath G, Evans CF, Whitton JL, Oldstone MB. 1995. CTL escape viral variants. II. Biologic activity in vivo. Virology 211:443-50
51. Van WC, Monach PA, Urban JL, Wortzel RD, Schreiber H. 1996. Immunodominance deters the response to other tumor antigens thereby favoring escape:prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens 41:399-407
52. Johnston JV, Malacko AR, Mizuno MT, McGowan P, Hellstrom I, Hellstrom KE, Marquardt H, Chen L. 1996. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes. J. Exp. Med. 183:791-800
53. van der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308-14
54. Hahn YS, Hahn CS, Braciale TJ. 1996. Endogenous presentation of a nascent antigenic epitope to CDS+ CTL is more efficient than exogenous presentation. Immunol. Cell Biol. 74:394-400
55. Shi Y, Smith KD, Kurilla MG, Lutz CT. 1997. Cytotoxic CDS+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts:immunodominance is elicited by a pcptide epitope that is presented at low levels in vitro. J. Immunol. 159:1844-52
56. Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ. 1995. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J. Exp. Med. 181:2221-28
57. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565-71
58. O'Herrin SM, Lebowitz MS, Bieler JG, al-Ramadi BK, Utz U, Bothwell AL, Schneck JP. 1997. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors. J. Exp. Med. 186:1333-45
59. Anton LA, Yewdell JW, Bennink JR. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158:2535-42
60. Restifo NP, Bacík I, Irvine KR, Yewdell JW, McCabe B, Anderson RW, Eisenlohr LC, Rosenberg SA, Bennink JR. 1995. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:4414-22
61. Tobery TW, Siliciano RF. 1997. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185: 909-20
62. Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-93
63. Vijh S, Pamer EG. 1997. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J. Immunol. 158:3366-71
64. Busch DH, Pilip IM, Vijh S, Pamer EG, 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 8:353-62
65. Busch DH, Pamer EG. 1998. MHC class I/peptide stability:implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 160:4441-48
66. Villanueva MS, Fischer P, Feen K, Pamer EG. 1994. Efficiency of MHC class I antigen processing:a quantitative analysis. Immunity 1:479-89
67. Vijh S, Pilip IM, Panier EG. 1998. Effect of antigen-processing efficiency on in vivo T cell response magnitudes. J. Immunol. 160:3971-77
68. Steven NM, Leese AM, Annels NE, Lee SP, Rickinson AB. 1996. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 184:1801-13
69. Levitsky V, Zhang Q-J, Levitskaya J, Masucci MG. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183:915-26
70. Yellen-Shaw AJ, Laughlin CE, Metrione RM, Eisenlohr LC. 1997. Murine transporter associated with antigen presentation (TAP) preferences, influence class I-restricted T cell responses. J. Exp. Med. 186:1655-62
71. Del Val M, Schlicht H-J, Ruppert T, Reddehase MJ, Koszinowski UH. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66:1145-53
72. Chen W, Khilko S, Fecondo J, Margulies DH, McCluskey J. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471-83
73. Niedermann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschützky H, Jung G, Maier B, Eichmann K. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289-99
74. Fu TM, Mylin LM, Schell TD, Bacik I, Russ G, Yewdell JW, Bennink JR, Tevethia SS. 1998. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J. Virol. 72:1469-81
75. Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengede E, Kloetzel PM, Neefjes J, Koszinowski U, Melief C. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115-24
76. Yellen-Shaw AJ, Wherry EJ, Dubois GC, Eisenlohr LC. 1997. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:3227-34
77. Neisig A, Roelse J, Sijts AJAM, Ossendorp F, Feltkamp MCW, Kast WM, Melief CJM, Neefjes JJ. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154:1273-79
78. Powis SJ, Young LL, Joly E, Barker PJ, Richardson L, Brandt RP, Melief CJ, Howard JC, Butcher GW. 1996. The rat cim effect:TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity 4:159-65
79. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-11
80. Rickinson AB, Lee SP, Steven NM. 1996. Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr. Op. Immunol. 8:492-97
81. Coupar BEH, Andrew ME, Both GW, Boyle DB. 1986. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur. J. Immunol. 16:1479-87
82. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD. 1991. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795-804
83. Zinkernagel RM, Althage A, Cooper S, Kreeb G, Klein PA, Sefton B, Flaherty L, Stimpfling J, Shreffler D, Klein J. 1978. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J. Exp. Med. 148:592-606
84. Doherty PC, Biddison WE, Bennink JR, Knowles BB. 1978. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J. Exp. Med. 148:534-43
85. Mylin LM, Bonneau RH, Lippolis JD, Tevethia SS. 1995. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665-77
86. Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C. 1997. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur. J. Immunol. 27:421-30
87. van der Most RG, Concepcion RJ, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Ahmed R, Sette A. 1997. Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice. J. Virol. 71:5110-14
88. Cole GA, Hogg TL, Coppola MA, Woodland DL. 1997. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. J. Immunol. 158:4301-9
89. + T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J. Immunol. 160:2923-31
90. Tussey LG, Rowland Jones S, Zheng TS, Androlewicz MJ, Cresswell P, Frelinger JA, McMichael AJ. 1995. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65-77
91. Von Herrath G, Dockter J, Nerenberg M, Gairin JE, Oldstone MB. 1994. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180:1901-10
92. Wettstein PJ. 1986. Immunodomnance in the T-cell response to multiple non-H-2 histocompatibity antigens. II. Observation of a hierarcy among dominant antigens, Immunogenetics 24:24-31
93. Bennink JR, Doherty PC. 1981. The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment. Cell Immunol. 61:220-24
94. Jamieson BD, Ahmed R. 1989. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J. Exp. Med. 169:1993-2005
95. Sandberg JK, Grufman P, Wolpert EZ, Franksson L, Chambers BJ, Karre K. 1998. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160:3163-69
96. Eberl G, Kessler B, Eberl LP, Brunda MJ, Valmori D, Corradin G. 1996. Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12. Eur. J. Immunol. 26:2709-16
97. Rowley DA, Stach RM. 1993. A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178:835-40
98. Stach RM, Rowley DA. 1993. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178:841-52
99. Rowley DA, Stach RM. 1998. B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. Int. Immunol. 10:355-63
100. Wentworth PA, Vitiello A, Sidney J, Keogh E, Chesnut RW, Grey H, Selle A. 1996. Differences and similarities in the A2. I-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 26:97-101
101. Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA. 1995. CTL responses of HLA-A2. 1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733-42
102. Engelhard VR, Lacy E, Ridge JP. 1991. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the MI protein. J. Immunol. 146:1226-32
103. Man S, Newberg MH, Crotzer VL, Luckey CJ, Williams NS, Chen Y, Huczko EL, Ridge JP, Engelhard VH. 1995. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. Int. Immunol. 7:597-605
104. Man S, Ridge JP, Engelhard VH. 1994. Diversity and dominance among TCR recognizing HLA-A2. 1+ influenza matrix peptide in human MHC class I transgenic mice. J. Immunol. 153:4458-67
105. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko TS, Argaet VP. 1995. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182:1703-15
106. Burrows SR, Khanna R, Burrows JM, Moss DJ. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179:1155-61
107. h epitope by Influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J. Exp. Med. 179:195-202
108. Cao W, Myers-Powell BA, Braciale TJ. 1996. The weak CD8+ CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J. Immunol. 157:505-11
109. Davis MM, McHeyzer-Williams M, Chien YH. 1995. T-cell receptor V-region usage and antigen specificity. The cytochrome c model system. Ann NY Acad. Sci. 756:1-11
110. Maryanski JL, Jongeneel CV, Bucher P, Casanova JL, Walker PR. 1996. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo:a high magnitude CDS response is comprised of very few clones. Immunity 4:47-55
111. Jones CM, Cose SC, Carbone FR. 1997. Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B. Int. Immunol. 9:1319-28
112. Campos-Lima PO, Levitsky V, Imreh MP, Gavioli R, Masucci MG. 1997. Epitopedependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 186:83-89
113. Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM, Moss DJ, Argaet VP, Misko IS. 1996. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J. Exp. Med. 184:1815-24
114. Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ. 1996. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat. Med. 2:906-11
115. b-restricted response to an influenza A virus nucleoprotein epitope. J. Immunol. 151:2658-66
116. Horwitz MS, Yanagi Y, Oldstone MB. 1994. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity. J. Virol. 68:352-57
117. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-71